Alexander D. Macrae

2021

In 2021, Alexander D. Macrae earned a total compensation of $4.7M as President and Chief Executive Officer at Sangamo Biosciences, a 23% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$446,223
Option Awards$2,047,009
Salary$688,615
Stock Awards$1,548,416
Other$5,554
Total$4,735,817

Macrae received $2M in option awards, accounting for 43% of the total pay in 2021.

Macrae also received $446.2K in non-equity incentive plan, $688.6K in salary, $1.5M in stock awards and $5.6K in other compensation.

Rankings

In 2021, Alexander D. Macrae's compensation ranked 2,786th out of 12,405 executives tracked by ExecPay. In other words, Macrae earned more than 77.5% of executives.

ClassificationRankingPercentile
All
2,786
out of 12,405
78th
Division
Manufacturing
1,102
out of 5,494
80th
Major group
Chemicals And Allied Products
435
out of 2,369
82nd
Industry group
Drugs
379
out of 2,090
82nd
Industry
Biological Products, Except Diagnostic Substances
110
out of 452
76th

Pay ratio

Alexander D. Macrae's Pay$4,735,817
Median Employee's Pay$170,218
Pay Ratio

28

to 1

In 2021, the annual total compensation of Alexander D. Macrae was $4,735,817.

The annual total compensation of the median employee at Sangamo Biosciences was $170,218.

The ratio of Alexander D. Macrae's pay to the pay of median employee was therefore 28 to one.

Source: SEC filing on April 1, 2022.

Macrae's colleagues

We found five more compensation records of executives who worked with Alexander D. Macrae at Sangamo Biosciences in 2021.

2021

Robert Schott

Sangamo Biosciences

Senior Vice President, Head of Development

2021

R Ramelmeier

Sangamo Biosciences

Executive Vice President, Technical Operations

2021

D McClung

Sangamo Biosciences

Chief Operating Officer

2021

Prathyusha Duraibabu

Sangamo Biosciences

Chief Financial Officer

2021

Sung Lee

Sangamo Biosciences

Chief Financial Officer

News

You may also like